| 1 |
Hargadon KM. Genetic dysregulation of immunologic and oncogenic signaling pathways associated with tumor-intrinsic immune resistance: a molecular basis for combination targeted therapy-immunotherapy for cancer. Cell Mol Life Sci 2023;80:40. [PMID: 36629955 DOI: 10.1007/s00018-023-04689-9] [Reference Citation Analysis]
|
| 2 |
Xiao J, Liu P, Wang Y, Zhu Y, Zeng Q, Hu X, Ren Z, Wang Y. A Novel Cognition of Decitabine: Insights into Immunomodulation and Antiviral Effects. Molecules 2022;27:1973. [DOI: 10.3390/molecules27061973] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 3 |
Kausar S, Liu R, Gul I, Abbas MN, Cui H. Transcriptome Sequencing Highlights the Regulatory Role of DNA Methylation in Immune-Related Genes’ Expression of Chinese Oak Silkworm, Antheraea pernyi. Insects 2022;13:296. [DOI: 10.3390/insects13030296] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 4 |
Han S, Tay JK, Loh CJL, Chu AJM, Yeong JPS, Lim CM, Toh HC. Epstein–Barr Virus Epithelial Cancers—A Comprehensive Understanding to Drive Novel Therapies. Front Immunol 2021;12:734293. [DOI: 10.3389/fimmu.2021.734293] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
|
| 5 |
Leong MML, Lung ML. The Impact of Epstein-Barr Virus Infection on Epigenetic Regulation of Host Cell Gene Expression in Epithelial and Lymphocytic Malignancies. Front Oncol 2021;11:629780. [PMID: 33718209 DOI: 10.3389/fonc.2021.629780] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 6 |
Cao Y, Xie L, Shi F, Tang M, Li Y, Hu J, Zhao L, Zhao L, Yu X, Luo X, Liao W, Bode AM. Targeting the signaling in Epstein-Barr virus-associated diseases: mechanism, regulation, and clinical study. Signal Transduct Target Ther 2021;6:15. [PMID: 33436584 DOI: 10.1038/s41392-020-00376-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 7 |
Uddin MA, Barabutis N. P53 in the impaired lungs. DNA Repair (Amst) 2020;95:102952. [PMID: 32846356 DOI: 10.1016/j.dnarep.2020.102952] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 8 |
Jing JJ, Li H, Wang ZY, Zhou H, Sun LP, Yuan Y. Aberrantly methylated-differentially expressed genes and pathways in Epstein-Barr virus-associated gastric cancer. Future Oncol 2020;16:187-97. [PMID: 31989840 DOI: 10.2217/fon-2019-0649] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 9 |
Huang H, Wu P, Zhang S, Shang Q, Yin H, Hou Q, Zhong J, Guo X. DNA methylomes and transcriptomes analysis reveal implication of host DNA methylation machinery in BmNPV proliferation in Bombyx mori. BMC Genomics 2019;20:736. [PMID: 31615392 DOI: 10.1186/s12864-019-6146-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 10 |
Feng DD, Cao Q, Zhang DQ, Wu XL, Yang CX, Chen YF, Yu T, Qi HX, Zhou GP. Transcription factor E2F1 positively regulates interferon regulatory factor 5 expression in non-small cell lung cancer. Onco Targets Ther 2019;12:6907-15. [PMID: 31692554 DOI: 10.2147/OTT.S215701] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 11 |
Afrasiabi A, Parnell GP, Fewings N, Schibeci SD, Basuki MA, Chandramohan R, Zhou Y, Taylor B, Brown DA, Swaminathan S, McKay FC, Stewart GJ, Booth DR. Evidence from genome wide association studies implicates reduced control of Epstein-Barr virus infection in multiple sclerosis susceptibility. Genome Med 2019;11:26. [PMID: 31039804 DOI: 10.1186/s13073-019-0640-z] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 12 |
Afrasiabi A, Parnell GP, Fewings N, Schibeci SD, Basuki MA, Chandramohan R, Brown DA, Swaminathan S, Mckay FC, Stewart GJ, Booth DR. Genetic evidence that the latency III stage of Epstein-Barr Virus infection is a therapeutic target for Multiple Sclerosis.. [DOI: 10.1101/390609] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 13 |
Kuss-Duerkop SK, Westrich JA, Pyeon D. DNA Tumor Virus Regulation of Host DNA Methylation and Its Implications for Immune Evasion and Oncogenesis. Viruses 2018;10:E82. [PMID: 29438328 DOI: 10.3390/v10020082] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 8.8] [Reference Citation Analysis]
|
| 14 |
Choi SJ, Shin YS, Kang BW, Kim JG, Won KJ, Lieberman PM, Cho H, Kang H. DNA hypermethylation induced by Epstein-Barr virus in the development of Epstein-Barr virus-associated gastric carcinoma. Arch Pharm Res 2017;40:894-905. [PMID: 28779374 DOI: 10.1007/s12272-017-0939-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 15 |
Nishikawa J, Iizasa H, Yoshiyama H, Nakamura M, Saito M, Sasaki S, Shimokuri K, Yanagihara M, Sakai K, Suehiro Y, Yamasaki T, Sakaida I. The Role of Epigenetic Regulation in Epstein-Barr Virus-Associated Gastric Cancer. Int J Mol Sci 2017;18:E1606. [PMID: 28757548 DOI: 10.3390/ijms18081606] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 16 |
Kang S, Myoung J. Primary lymphocyte infection models for KSHV and its putative tumorigenesis mechanisms in B cell lymphomas. J Microbiol 2017;55:319-29. [PMID: 28455586 DOI: 10.1007/s12275-017-7075-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 17 |
Birdwell CE, Queen K, Scott RS. Epigenetic Consequences of Epstein–Barr Virus Infection. Epigenetics of Infectious Diseases 2017. [DOI: 10.1007/978-3-319-55021-3_4] [Reference Citation Analysis]
|
